Drugs
(Drugs) 《药物》
2013年影响因子
4.133
- 2012-10-11•肌内注射缓释型棕榈酸帕潘立酮:对其用于精神分裂症治疗的综述
- 2012-10-16•两相门冬胰岛素30十年经验:从药物研发到最近临床发现
- 2012-10-16•通过尼古丁疫苗协助戒烟:研究现状
- 2012-10-16•HIV-1抗逆转录病毒耐药性:科学原则和临床应用
最新一期
Adjuvant Therapy for High-Risk Gastrointestinal Stromal Tumour: Considerations for Optimal Management
Drugs. 72(15):1953-1963, October 22, 2012.
doi: 10.2165/11635590-000000000-00000
Therapy In Practice
Management of Bleeding in Patients Receiving Conventional or New Anticoagulants: A Practical and Case-Based Approach
Drugs. 72(15):1965-1975, October 22, 2012.
doi: 10.2165/11641160-000000000-00000
Review Article
Sublingual vs Oral Immunotherapy for Food Allergy: Identifying the Right Approach
Drugs. 72(15):1977-1989, October 22, 2012.
doi: 10.2165/11640800-000000000-00000
Original Research Article
Comparison of Amoxicillin/Clavulanic Acid High Dose with Cefdinir in the Treatment of Acute Otitis Media
Drugs. 72(15):1991-1997, October 22, 2012.
doi: 10.2165/11590320-000000000-00000
Adis Drug Profiles
Aclidinium: In Chronic Obstructive Pulmonary Disease
Drugs. 72(15):1999-2011, October 22, 2012.
doi: 10.2165/11209700-000000000-00000
Ferumoxytol: In Iron Deficiency Anaemia in Adults With Chronic Kidney Disease
Drugs. 72(15):2013-2022, October 22, 2012.
doi: 10.2165/11209880-000000000-00000
Carfilzomib: In Relapsed, or Relapsed and Refractory, Multiple Myeloma
Drugs. 72(15):2023-2032, October 22, 2012.
doi: 10.2165/11209010-000000000-00000
R&D Insight Profile
Phentermine and Topiramate Extended Release (Qsymia™): First Global Approval
Drugs. 72(15):2033-2042, October 22, 2012.
doi: 10.2165/11640860-000000000-00000